Increased expression of HIV co-receptor CXCR4 on CD4+ T-cells in patients with active visceral leishmaniasis

Scandinavian Journal of Infectious Diseases

Volumn 36, Issue 1, 2004, Pages 56-58

  Hailu, Asrat ^a   Pater, Jennie M ^b   Kager, Piet A ^b   Van Der Poll, Tom ^b  

^a ADDIS ABABA UNIVERSITY   (Ethiopia)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMONY GLUCONATE; CD4 ANTIGEN; CD8 ANTIGEN; CHEMOKINE RECEPTOR CXCR4;

ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; ARTICLE; BLOOD SAMPLING; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION SENSITIVITY; LEISHMANIA; MALE; PROTEIN EXPRESSION; T LYMPHOCYTE; VISCERAL LEISHMANIASIS;

ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; CD4-POSITIVE T-LYMPHOCYTES; CHILD; COHORT STUDIES; COMORBIDITY; FEMALE; HIV INFECTIONS; HUMANS; INCIDENCE; LEISHMANIASIS, VISCERAL; MALE; NETHERLANDS; PROBABILITY; RECEPTORS, CXCR4; RECEPTORS, HIV; RISK FACTORS; SENSITIVITY AND SPECIFICITY; VIRAL LOAD;

EID: 1242319438     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365540310017546     Document Type: Article

References (11)

1. Alvar J, Canavate C, Gutierrez-Solar B, Jimenez M, Laguna F, Lopez-Velez R, et al. Leishmania and human immunodeficiency virus co-infection: the first 10 y. Clin Microbiol Rev 1997; 10: 298-319.
2. Wolday D, Berhe N, Akuffo H, Britton S. Leishmania-HIV interaction: immunopathogenic mechanisms. Parasitol Today 1999; 15: 182-7.
3. Bernier R, Turco SJ, Olivier M, Tremblay M. Activation of human immunodeficiency virus type 1 in monocytoid cells by the protozoan parasite Leishmania donovani. J Virol 1995; 69: 7282-5.
4. Toossi Z, Sierra-Madero JG, Blinkhorn RA, Mettler MA, Rich EA. Enhanced susceptibility of blood monocytes from patients with pulmonary tuberculosis to productive infection with human immunodeficiency virus type 1. J Exp Med 1993; 177: 1511-6.
5. Goletti D, Weissman D, Jackson RW, Graham NM, Vlahov D, Klein RS, et al. Effect of Mycobacterium tuberculosis on HIV replication: role of immune activation. J Immunol 1996; 157: 1271-8.
6. Berger EA, Murphy PM, Farber JM. Chemokine receptors as HIV-1 co-receptors: roles in viral entry, tropism, and disease. Annu Rev Immunol 1999; 17: 657-700.
7. Dolei A, Biolchini A, Serra C, Curreli S, Gomes E, Dianzani F. Increased replication of T-cell-tropic HIV strains and CXC-chemokine receptor-4 induction in T-cells treated with macrophage inflammatory protein (MIP)-1alpha, MIP-1beta and RANTES beta-chemokines. Aids 1998; 12: 183-90.
8. Juffermans NP, Paxton WA, Dekkers PE, Verbon A, de Jonge E, Speelman P, et al. Up-regulation of HIV co-receptors CXCR4 and CCR5 on CD4+ T-cells during human endotoxaemia and after stimulation with (myco)bacterial antigens: the role of cytokines. Blood 2000; 96: 2649-54.
9. Juffermans NP, Speelman P, Verbon A, Veenstra J, Jie C, van Deventer SJ, et al. Patients with active tuberculosis have increased expression of HIV coreceptors CXCR4 and CCR5 on CD4+ T-cells. Clin Infect Dis 2001; 32: 650-2.
10. Dasgupta B, Roychoudhury K, Ganguly S, Akbar MA, Das P, Roy S. Infection of human mononuclear phagocytes and macrophage-like THP1 cells with Leishmania donovani results in modulation of expression of a subset of chemokines and a chemokine receptor. Scand J Immunol 2003; 57: 366-74.
11. Connor RI, Sheridan KE, Ceradini D, Choe S, Landau NR. Change in coreceptor use correlates with disease progression in HIV-1-infected individuals. J Exp Med 1997; 185: 621-8.